PharmaNet Consulting professionals with significant experience in product development and international regulatory guidelines provide advice on topics covering the entire spectrum of development. Our professionals include former senior-level FDA officials and other international regulatory experts who are available to help address obstacles that may occur throughout product development. Former FDA officials available for consultation include:
Andrew Chang, PhD, Executive Director
Former FDA Associate Director for Policy and Regulation, Division of Hematology
William M. Egan, PhD, Executive Director
Former FDA Deputy Director and Acting Director for the Office of Vaccines
Research
and Review
Joyce Lea Frey-Vasconcells, PhD, Executive Director
Former FDA Deputy Director, Office of Cellular, Tissue, and Gene Therapies
Duu-Gong Wu, PhD, Executive Director
Former FDA Deputy Division Director of Division of New Drug Chemistry II
Key Product Areas
504 Carnegie Center, Princeton, NJ 08540